AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18700216
Drug: Antipsychotic medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic medications (general)
Trial: 19996309
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin administration
Trial: 9589972
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of RA using acupuncture (A)
Trial: 3947490
Drug: 0.75% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% bupivacaine 2.7 ml at L2/3 (Group C)
Trial: 3947490
Drug: 0.75% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% bupivacaine 2 ml at L3/4 (Group D)
Trial: 3947490
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine 4 ml at L3/4 (Group B)
Trial: 3947490
Drug: 0.75% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% bupivacaine 2.7 ml at L3/4 (Group A)
Trial: 28201994
Drug: Risedronate (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate (2.5 mg once daily or 17.5 mg once weekly)
Trial: 26066773
Drug: Thiamine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiamine (300 mg in 0.9% Normal saline solution)
Trial: 21733421
Drug: Subcutaneous local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous local anesthetic mixture under the tourniquet
Trial: 7506146
Drug: Nimesulide treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide treatment for 7 to 10 days
Trial: 7506146
Drug: Nimesulide in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide in combination with ambroxol
Trial: 26653067
Drug: mHealth intervention
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mHealth intervention with monthly motivational counselling calls and weekly personalised text messages for 12 months
Trial: 24566244
Drug: Sevoflurane (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane (0.5 to 3.5 vol%) and Remifentanil (0 to 12 ng/ml)
Trial: 20121764
Drug: Extra-fine beclomethasone/formoterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra-fine beclomethasone/formoterol (BDP/F) 400/24 microg daily
Trial: 20121764
Drug: Fluticasone propionate/salmeterol
RxNorm normalized name: fluticasone propionate/salmeterol 100/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate/salmeterol (FP/S) 500/100 microg daily
Trial: 10520055
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray (200 microg, twice daily)
Trial: 1675050
Drug: Flurbiprofen sodium
RxNorm normalized name: Flurbiprofen Sodium
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen sodium 0.03% (topically administered to one eye)
Trial: 1675050
Drug: Placebo (topically
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (topically administered to the contralateral eye)
Trial: 29935595
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (acustimulation/dexamethasone)
Trial: 26679243
Drug: Delafloxacin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delafloxacin (300 mg, intravenously, twice daily for 5-14 days)
Trial: 26679243
Drug: Vancomycin (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (15 mg/kg, intravenously, twice daily for 5-14 days)
Trial: 26679243
Drug: Linezolid (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid (600 mg, intravenously, twice daily for 5-14 days)
Trial: 24563440
Drug: Normobaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normobaric oxygen therapy (NBOT)
Trial: 17593070
Drug: Pantoprazole granules
RxNorm normalized name: pantoprazole Granule Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole granules (40 mg)
Trial: 17593070
Drug: Pantoprazole tablets
DrugBank: Pantoprazole (DB00213)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pantoprazole tablets (40 mg)
Trial: 14976607
Drug: Praziquantel and
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel and mebendazole (treatment every 3 months)
Trial: 10404023
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of lactulose
Trial: 10404023
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of lactulose
Trial: 2175022
Drug: Traditional multi-vitamin
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional multi-vitamin treatment
Trial: 10359410
Drug: Once-weekly isoniazid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly isoniazid (900 mg) and rifapentine (600 mg)
Trial: 10359410
Drug: Twice-weekly isoniazid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly isoniazid (900 mg) and rifampin (600 mg)
Trial: 1850691
Drug: Beet fiber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beet fiber supplementation (16 g added to ordinary diet)
Trial: 6121836
Drug: Bromazepam (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromazepam (6 mg daily: 1.5 mg at 7 a.m., 1.5 mg at 3 p.m., 3 mg at 11 p.m.)
Trial: 6121836
Drug: Placebo (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (same dosage pattern as bromazepam)
Trial: 15181054
Drug: Metformin (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1000 mg/d)
Trial: 15155303
Drug: IA saline
RxNorm normalized name: CVS Milk of Magnesia Saline Laxative 1200mg/15mL Suspension (Mint)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IA saline 10 mL
Trial: 17138192
Drug: IA saline
RxNorm normalized name: CVS Milk of Magnesia Saline Laxative 1200mg/15mL Suspension (Mint)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IA saline 1 mL (placebo)
Trial: 9886506
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg leuprolide acetate (GnRHa) for ovulation induction
Trial: 11403367
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg q.d.
Trial: 23622917
Drug: Intra-arterial contrast
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial contrast injection
Trial: 23622917
Drug: Intravenous contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous contrast administration
Trial: 20639734
Drug: Naprapathic manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naprapathic manual therapy
Trial: 16968504
Drug: IV pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV pantoprazole (PAN) 80 mg plus 8 mg/h for 72 h
Trial: 16968504
Drug: IV ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ranitidine (RAN) 50 mg plus 6.25 mg/h for 72 h
Trial: 9108644
Drug: Trihexyphenidyl (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trihexyphenidyl (8 mg)
Trial: 9108644
Drug: Biperiden (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biperiden (6 mg)
Trial: 8099803
Drug: Metoprolol, 50
RxNorm normalized name: Hydrochlorothiazide-Metoprolol, 50 mg-100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol, 50 mg three times daily
Trial: 8099803
Drug: Propranolol, single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol, single 40 mg dose
Trial: 2869703
Drug: Lactate infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactate infusions
Trial: 2869703
Drug: Chronic alprazolam
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic alprazolam treatment
Trial: 31362262
Drug: EIMD group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EIMD group received a treatment to induce muscle damage consisting of a weight lifting protocol directed to the agonist muscles related to the task prior to the pretest and to the learning sessions.
Trial: 31362262
Drug: CON group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CON group (control group) did not receive the EIMD treatment.
Trial: 30218170
Drug: Home intravenous
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home intravenous (IV) ertapenem
Trial: 30218170
Drug: Oral amoxicillin‐clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin‐clavulanate
Trial: 26368863
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment responders
Trial: 9922346
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (1.5 x 10^6 U over 30 to 60 minutes)
Trial: 442224
Drug: peptichemio at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: peptichemio at 1.2 mg/kg twice weekly
Trial: 442224
Drug: peptichemio at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: peptichemio at 0.9 mg/kg twice weekly
Trial: 442224
Drug: peptichemio at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: peptichemio at 1.3 mg/kg once weekly combined with other cytostatic drugs
Trial: 27265706
Drug: Lifestyle coaching
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle coaching plus care coordination plus treatment as usual (N=138)
Trial: 27265706
Drug: Care coordination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Care coordination plus treatment as usual (N=142)
Trial: 27265706
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual alone (N=148)
Trial: 25124733
Drug: Capsaicin-contained red
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin-contained red pepper sauce (acute infusion)
Trial: 25124733
Drug: Capsaicin-contained red
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin-contained red pepper sauce (repeated infusion)
Trial: 21921823
Drug: 2‐nitrooxy ethyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2‐nitrooxy ethyl 2‐amino 3‐methylbutanoate gel
Trial: 17472154
Drug: Warmed intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warmed intravenous fluids using a dry IV fluid warmer (normothermia group)
Trial: 17472154
Drug: Room temperature
RxNorm normalized name: ROOM DEODORIZER POWDER MENTOR #3202
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Room temperature intravenous fluids (hypothermia group)
Trial: 9861410
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose of quinine (20 mg/kg)
Trial: 9861410
Drug: No loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No loading dose of quinine
Trial: 25574674
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg + 2800 IU cholecalciferol once per week
Trial: 20401289
Drug: Daflon (micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daflon (micronized purified flavonoid fraction) 500 mg (6 tablets daily for 4 days, followed by 2 tablets for 3 days)
Trial: 18270352
Drug: Experimental strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental strategy (n = 475): target tidal volumes of 6 mL/kg of predicted body weight, plateau pressures not exceeding 40 cm H2O, recruitment maneuvers, and higher positive end‐expiratory pressures.
Trial: 18270352
Drug: Control strategy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control strategy (n = 508): target tidal volumes of 6 mL/kg of predicted body weight, plateau airway pressures not exceeding 30 cm H2O, and conventional levels of positive end‐expiratory pressure.
Trial: 15885294
Drug: 800 IU
RxNorm normalized name: Vitamin E 800 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 IU daily oral vitamin D3
Trial: 15885294
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg calcium
Trial: 15885294
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 800 IU vitamin D3 and 1000 mg calcium
Trial: 10974132
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone (2 mg through a metered-dose inhaler with a spacer)
Trial: 10974132
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (2 mg per kilogram of body weight)
Trial: 1505150
Drug: Sch 37370
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sch 37370 (5 mg/kg)
Trial: 30058829
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU; n = 85)
Trial: 20444767
Drug: Direct referral
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct referral to a cessation clinic (CC)
Trial: 18767591
Drug: Tendon‐muscle picking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tendon‐muscle picking therapy
Trial: 15811059
Drug: SRP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP and metronidazole (M, 400 mg tid) for 10 days (T1)
Trial: 15811059
Drug: SRP, weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP, weekly professional supragingival plaque removal for 3 months (PC) and placebo (T2)
Trial: 12395912
Drug: Acemetacin 60
RxNorm normalized name: acemetacin 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acemetacin 60 mg t.i.d.
Trial: 7560468
Drug: Nebulized adrenaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized adrenaline (2 mg over 10 min)
Trial: 7560468
Drug: Nebulized salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized salbutamol (5 mg over 10 min)
Trial: 6853746
Drug: fenoterol hydrobromide
RxNorm normalized name: Fenoterol hydrobromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fenoterol hydrobromide (0.5, 1.25, and 2.5 mg)
Trial: 6853746
Drug: isoproterenol (2.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isoproterenol (2.8 mg) with phenylephrine (1.25 mg)
Trial: 6853746
Drug: isoetharine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isoetharine (5 mg) with phenylephrine (1.25 mg)
Trial: 21928233
Drug: Bicarbonate treatment
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicarbonate treatment group (Bic)
Trial: 21928233
Drug: Usual-treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual-treatment group (no-Bic)
Trial: 19397672
Drug: LED treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LED treatment with a 590-nm wavelength LED array
Trial: 21040410
Drug: Telbivudine 600
RxNorm normalized name: telbivudine 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telbivudine 600 mg/day for 1 year
Trial: 21040410
Drug: Lamivudine 100
RxNorm normalized name: lamivudine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine 100 mg/day for 1 year
Trial: 12237663
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (1000 mg/d) and Vitamin E (400 IU/d) supplementation
Trial: 12237663
Drug: Women at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Women at low risk (no supplements)
Trial: 1788614
Drug: Gemfibrozil (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (900 mg daily)
Trial: 1788614
Drug: Phenofibrate (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenofibrate (300 mg daily)
Trial: 25229779
Drug: Povidone-iodine topical
RxNorm normalized name: povidone-iodine Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Povidone-iodine topical antiseptic
Trial: 25229779
Drug: Vapocoolant spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vapocoolant spray (1,1,1,3,3 pentafluoropropane and 1,1,1,2‐tetrafluoroethane)
Trial: 20144207
Drug: loratadine (antihistamine)
RxNorm normalized name: Loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: loratadine (antihistamine)
Trial: 12915681
Drug: Candesartan (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (16 mg/d)
Trial: 15938033
Drug: Amlodipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (10 mg/d)
Trial: 1751798
Drug: alpha-IFN therapy
RxNorm normalized name: IFN .ALPHA.-1B
DrugBank: Interferon alfa-1b (DB18522)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-IFN therapy alone
Trial: 1751798
Drug: Prednisone priming
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone priming with IFN therapy
Trial: 1751798
Drug: IFN therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN therapy alone
Trial: 6113192
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg bd
Trial: 6109686
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg tds and 400 mg at night
Trial: 25624430
Drug: Everolimus (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus (10 mg daily) and Letrozole (2.5 mg daily)
Trial: 30872130
Drug: Folate receptor-positive
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folate receptor-positive circulating tumour cells (FR+-CTCs)
Trial: 30872130
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of FR+-CTC count and maximum tumour diameter (MTD)
Trial: 27227460
Drug: Electroacupuncture (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture (EA) treatment, 3 weekly sessions
Trial: 22126102
Drug: Brief Intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Intervention (BI) for illicit drugs (cannabis, cocaine, amphetamine-type stimulants, opioids)
Trial: 22126102
Drug: Brief Intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Intervention (BI) for stimulants
Trial: 18397695
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (133.3 mg lopinavir/33.3 mg ritonavir)
Trial: 18397695
Drug: Reference product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference product (Kaletra 133.3 mg lopinavir/33.3 mg ritonavir)
Trial: 15647968
Drug: Higher molecular
RxNorm normalized name: Molecular AF
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher molecular weight viscosupplement (hylan G‐F 20, Synvisc)
Trial: 9174876
Drug: Aerosolized heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized heparin inhalation (1,000 U/kg)
Trial: 2677269
Drug: Empiric care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric care (high-dose antacid therapy: 15-30 ml of high-potency antacid one and three hours after meals and at bedtime)
Trial: 30657120
Drug: 1 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml/kg of 0.25% caudal bupivacaine mixed with 2 μg/kg neostigmine (group BN)
Trial: 30657120
Drug: 1 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml/kg of 0.25% caudal bupivacaine mixed with 50 mcg/kg midazolam (group BM)
Trial: 30657120
Drug: 1 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml/kg of 0.25% caudal bupivacaine mixed with 0.5 mg/kg ketamine (group BK)
Trial: 30657120
Drug: 1 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml/kg of 0.25% caudal bupivacaine (group B)
Trial: 29911776
Drug: Multi-concentration level
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-concentration level patch test guided DPCP treatment
Trial: 29911776
Drug: Conventional DPCP
RxNorm normalized name: DPCPX
DrugBank: DPCPX (DB12946)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional DPCP treatment
Trial: 26123919
Drug: Single-dose study
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose study in men
Trial: 23473374
Drug: 0.5 mg/ml
RxNorm normalized name: urea 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/ml mitomycin C (MMC) applied at the site of discectomy for 5 minutes
Trial: 19594864
Drug: Probiotic group
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic group (L. gasseri CECT5714 and L. coryniformis CECT5711)
Trial: 2801589
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate supplement (1500 mg Ca/d)